UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: January 16, 2006
(Date of earliest event reported)
ABIOMED, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
04-2743260 |
|
(State or Other Jurisdiction of |
|
(IRS Employer Identification |
|
|
|
|
|
001-09585 |
||
|
(Commission File Number) |
||
|
|
|
|
|
22 Cherry Hill Drive |
||
|
(Address of Principal Executive Offices, including Zip Code) |
||
|
|
|
|
|
(978) 777-5410 |
||
|
(Registrant’s Telephone Number, including Area Code) |
||
|
|
|
|
Not Applicable |
||
|
(Former Name or Former Address, if Changed Since Last Report) |
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Election of Director.
On January 16, 2006, ABIOMED, Inc. announced the election of Ronald W. Dollens, retired president and chief executive officer of Guidant Corporation, as a member of its Board of Directors. Mr. Dollens will serve as a Class I director for the remainder of the Class I term and thereafter if he is re-elected. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statement And Exhibits
(d) Exhibits
99.1 January 16, 2006 Press Release
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
ABIOMED, Inc. |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Daniel J. Sutherby |
|
|
|
|
Daniel.J. Sutherby |
|
|
|
|
Principal Financial Officer |
|
Date: January 18, 2006
3